BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31091594)

  • 1. [Clinical prognostic factors of adult supratentorial glioblastoma].
    Jiang HH; Ren XH; Cui Y; Li MX; Yang KY; Lei YF; Lin S
    Zhonghua Wai Ke Za Zhi; 2019 May; 57(5):377-382. PubMed ID: 31091594
    [No Abstract]   [Full Text] [Related]  

  • 2. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection.
    Shinoda J; Sakai N; Murase S; Yano H; Matsuhisa T; Funakoshi T
    J Neurooncol; 2001 Apr; 52(2):161-71. PubMed ID: 11508816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis.
    Jeswani S; Nuño M; Folkerts V; Mukherjee D; Black KL; Patil CG
    Neurosurgery; 2013 Aug; 73(2):240-6; discussion 246; quiz 246. PubMed ID: 23615082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factor analysis of cerebrospinal fluid spread in glioblastoma].
    Huang J; Li MX; Ma ML; Ren XH; Cui Y; Lin S
    Zhonghua Wai Ke Za Zhi; 2020 Jun; 58(6):469-474. PubMed ID: 32498488
    [No Abstract]   [Full Text] [Related]  

  • 5. Supratentorial glioblastoma treated with radiotherapy: use of the Radiation Therapy Oncology Group recursive partitioning analysis grouping for predicting survival.
    Fujii O; Soejima T; Kuwatsuka Y; Harada A; Ota Y; Tsujino K; Sasaki M; Kudo H; Nishihara M; Taomoto K
    Jpn J Clin Oncol; 2010 Aug; 40(8):726-31. PubMed ID: 20410057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Analysis of Survival Outcomes and Prognostic Factors of Supratentorial versus Cerebellar Glioblastoma in the Elderly: Does Location Really Matter?
    Chandra A; Lopez-Rivera V; Dono A; Brandel MG; Lewis C; O'Connor KP; Sheth SA; Ballester LY; Aghi MK; Esquenazi Y
    World Neurosurg; 2021 Feb; 146():e755-e767. PubMed ID: 33171326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment results and outcome in elderly patients with glioblastoma multiforme--a retrospective single institution analysis.
    Hoffermann M; Bruckmann L; Kariem Mahdy A; Asslaber M; Payer F; von Campe G
    Clin Neurol Neurosurg; 2015 Jan; 128():60-9. PubMed ID: 25462098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome and prognostic factors in adult cerebellar glioblastoma.
    Babu R; Sharma R; Karikari IO; Owens TR; Friedman AH; Adamson C
    J Clin Neurosci; 2013 Aug; 20(8):1117-21. PubMed ID: 23706183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.
    Mohan DS; Suh JH; Phan JL; Kupelian PA; Cohen BH; Barnett GH
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):981-7. PubMed ID: 9869219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of glioblastoma treated with a moderately escalated radiation dose-Results of a retrospective analysis.
    Shieh LT; Guo HR; Ho CH; Lin LC; Chang CH; Ho SY
    PLoS One; 2020; 15(5):e0233188. PubMed ID: 32413077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence.
    Fukui A; Muragaki Y; Saito T; Maruyama T; Nitta M; Ikuta S; Kawamata T
    World Neurosurg; 2017 Feb; 98():73-80. PubMed ID: 27989974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme.
    Cetin B; Gonul II; Gumusay O; Bilgetekin I; Algin E; Ozet A; Uner A
    Neuropathology; 2018 Oct; 38(5):457-462. PubMed ID: 29952031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomic and educational factors interference in the prognosis for glioblastoma multiform.
    Lynch JC; Welling L; Escosteguy C; Pereira AG; Andrade R; Pereira C
    Br J Neurosurg; 2013 Feb; 27(1):80-3. PubMed ID: 22900509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 serine 727 phosphorylation influences clinical outcome in glioblastoma.
    Lin GS; Chen YP; Lin ZX; Wang XF; Zheng ZQ; Chen L
    Int J Clin Exp Pathol; 2014; 7(6):3141-9. PubMed ID: 25031733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.
    Hollon T; Nguyen V; Smith BW; Lewis S; Junck L; Orringer DA
    J Neurosurg; 2016 Aug; 125(2):410-8. PubMed ID: 26745489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
    Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
    Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme.
    Shinojima N; Kochi M; Hamada J; Nakamura H; Yano S; Makino K; Tsuiki H; Tada K; Kuratsu J; Ishimaru Y; Ushio Y
    J Neurosurg; 2004 Aug; 101(2):219-26. PubMed ID: 15309911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma.
    Lin GS; Yang LJ; Wang XF; Chen YP; Tang WL; Chen L; Lin ZX
    Med Oncol; 2014 Apr; 31(4):924. PubMed ID: 24652192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression.
    Mu L; Wang Y; Wang Y; Zhang H; Shang D; Tan F; Li Y; Chen X
    World Neurosurg; 2017 Jan; 97():279-283. PubMed ID: 27744078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma treated with postoperative radio-chemotherapy: prognostic value of apparent diffusion coefficient at MR imaging.
    Yamasaki F; Sugiyama K; Ohtaki M; Takeshima Y; Abe N; Akiyama Y; Takaba J; Amatya VJ; Saito T; Kajiwara Y; Hanaya R; Kurisu K
    Eur J Radiol; 2010 Mar; 73(3):532-7. PubMed ID: 19250783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.